Skip to content

Ginkgo Bioworks DNA Income Statement

FY'25FY'24FY'23FY'22
$160.07M-29.5%$227.04M-9.7%$251.46M-47.4%$477.71M+52.2%
$243.77M-42.5%$424.06M-27.0%$580.62M-44.8%$1.05B-8.4%
$173.97M-29.3%$246.16M-36.1%$385.03M-73.1%$1.43B+65.7%
-$307.28M+45.1%-$559.76M+35.2%-$864.41M+60.9%-$2.21B-20.8%
-192%+54.6pp-246.5%+97.2pp-343.8%+119pp-462.4%+120pp
-$28.53M-133%$87.55M
-$20.33M+46.8%-$38.2M+30.3%-$54.83M-2.8%-$53.34M-362%
-$305.95M+44.1%-$547.51M+38.7%-$892.94M+57.9%-$2.12B-15.4%
-$837K-74.7%-$479K-575%-$71K+99.5%-$15.03M-915%
-$5.65+46.6%-$10.58+1.0%-$10.69+78.7%-$50.15-3,615%
220.2M+7.1%205.6M-94.8%3.9B-19.5%4.9B
-$309.11M+43.8%-$550.32M+38.1%-$888.75M+57.8%-$2.11B-14.6%
-$917K
-$3.29M-180%$4.12M
-$28.53M-133%$87.55M
$3.87M-57.6%$9.14M+19.7%$7.63M+541%
$10.59M-56.2%$24.17M$0$0
$160.07M-29.5%$227.04M-9.7%$251.46M-47.4%$477.71M+52.2%
-$307.28M+45.1%-$559.76M+35.2%-$864.41M+60.9%-$2.21B-20.8%
-$248.29M+50.0%-$496.74M+37.4%-$793.9M+63.4%-$2.17B-20.4%
-$248.29M+50.0%-$496.74M+37.4%-$793.9M+63.4%-$2.17B-20.4%
-155.1%+63.7pp-218.8%+96.9pp-315.7%+138pp-453.5%+120pp
-$307.28M+45.1%-$559.76M+35.2%-$864.41M+60.9%-$2.21B-20.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Ginkgo Bioworks's revenue?
Ginkgo Bioworks (DNA) generated $141.3M in revenue over the trailing twelve months, down 37.8% year over year.
Is Ginkgo Bioworks profitable?
Ginkgo Bioworks is not currently profitable: it reported a net loss of $304.4M over the trailing twelve months, a -215.4% net margin.
Where does Ginkgo Bioworks's income statement data come from?
Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.